Oct 2026· Cellular Signalling· Vol 149, pp.
112952
· 0 citations· 71 references
Medicine
TL;DR
These findings delineate a circNFAT5/miR-552-3p/FoxO1/UBC regulatory axis associated with PI3K/AKT signaling that may contribute to BCa progression, nominating FoxO1 as a candidate prognostic biomarker and a potential therapeutic stratification marker.
Abstract
Bladder cancer (BCa) is a prevalent urological malignancy characterized by high recurrence rates and limited therapeutic options for advanced disease. Circular RNAs (circRNAs) have emerged as critical regulators of gene expression in cancer, yet their roles in BCa progression remain incompletely understood. Here, circ_0006845 (circNFAT5) is identified as a tumor-suppressive circRNA that is significantly downregulated in BCa tissues and cell lines. Functional assays demonstrate that circNFAT5 inhibits BCa cell proliferation, migration, and invasion in vitro and suppresses subcutaneous tumor growth in vivo. Mechanistically, circNFAT5 localizes predominantly to the cytoplasm and functions as a competing endogenous RNA (ceRNA) by competitively sponging miR-552-3p, thereby relieving post-transcriptional repression of the Forkhead box O1 (FoxO1) transcription factor. Single-cell RNA sequencing analysis further identifies Ubiquitin C (UBC) as a potential downstream target of FoxO1, with FoxO1 occupancy at the UBC promoter supported by ChIP-seq and computational docking predicting a potential interaction. Intercellular communication profiling identifies ANNEXIN, COMPLEMENT, SEMA3, VEGF, and VISFATIN as dominant PI3K/AKT-associated axis mediating cross-talk between FoxO1-low tumor subpopulations and stromal cells within the tumor microenvironment. Drug sensitivity analysis predicts that FoxO1-low BCa cells may exhibit enhanced sensitivity to cisplatin, gemcitabine, and PI3K/AKT/mTOR pathway inhibitors. These findings delineate a circNFAT5/miR-552-3p/FoxO1/UBC regulatory axis associated with PI3K/AKT signaling that may contribute to BCa progression, nominating FoxO1 as a candidate prognostic biomarker and a potential therapeutic stratification marker.
Simple Summary Circular RNAs (circRNAs) are evolutionarily conserved, covalently closed-loop RNAs with greater stability than linear transcripts. Their differential expression between tumor and adjacent non-malignant tissues, together with their involvement in multiple hallmarks of tumor progression, positions circRNAs...
Ling He, Bin Liu, Zhao-Yong Li· Cancers· 0 citations
Objective Gastric carcinoma (GC) is a leading cause of cancer-related mortality, often driven by epigenetic dysregulation. This study investigates the role of Retinoblastoma-binding protein 2 (RBP2), a chromatin-associated transcriptional regulator frequently overexpressed in GC. We specifically focus on elucidating ho...
Pan-Pan Tang, Ping Song, Xi-Zeng Li et al.· Frontiers in Oncology· 0 citations
Findings support a circENO1-SPI1-ENO1 regulatory axis linking malignant phenotypes and glycolytic activity in GC and require further clinical and preclinical validation to establish its broader biological and translational relevance.
The findings unveil a novel USP3-NPM1 signaling axis that critically maintains chromatin homeostasis and drives chemoresistance, highlighting that targeting USP3 may be a highly promising therapeutic strategy for advanced BCa.
Hao Wan, Hong-Ji Hu, Jia-Hao Liu et al.· Cell Death & Disease· 0 citations
Melanoma is a highly aggressive malignancy characterized by significant phenotypic plasticity, allowing tumor cells to transit between different phenotypic states. This process, known as phenotype switching, drives metastasis and therapeutic resistance. While the primary transcriptional markers defining these state...
Lucrezia De Santis, Alessandro De Santis, V. Amico et al.· Cell Death Discovery· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.